Big Pharma invents ‘Sluggish Cognitive Tempo’ disease to drug millions more children
The drug industry has come up with yet another phony mental illness that it says afflicts as many as 2 million children: "Sluggish Cognitive Tempo," or SCT, one of the most ridiculous counterfeit diseases yet. According to a description of the "disease" published in the Journal of Abnormal Child Psychology, children with SCT are basically daydreamers, which Big Pharma is now using as a catch-net classification for children who can't be declared as having attention-deficit hyperactivity disorder (ADHD).
The emergence of SCT comes as parents, medical professionals and child psychologists increasingly question the validity of the millions of ADHD diagnoses that are really just cases of kids being kids. In order to keep these children drugged up and the cash flowing, the psychiatric and drug industries basically invented SCT as a fallback. In other words, when an ADHD diagnosis doesn't fly, declare the child to have SCT.
Many of the children currently diagnosed with ADHD don't exhibit actual signs of hyperactivity, for instance. And yet some of them aren't performing in school as well as their teachers or parents would like, which in years past may have been enough to make an ADHD diagnosis. But the public is wising up to the scam, hence the invention of SCT.
"As a former mental health therapist, I can barely hold back my laughter at this thinly veiled attempt to separate parents from their hard earned money by making them think that... their perfectly normal child is mentally ill," wrote Dave Hodges for The Common Sense Show. "The main characteristics of [SCT] are vaguely described but include some combination of daydreaming, lethargy and slow mental processing, you know, like we do when we watch television."
Eli Lilly waiting like a vulture to medicate kids for SCT
Though the alleged condition isn't mentioned by name in the official Diagnostic and Statistical Manual (DSM), the sacred text of the psychiatric religion, SCT is clearly described as a supposed subtype of ADHD, which as we previously reported is also a made-up condition. To overcome the hyperactivity misnomer in some diagnosed children, the DSM simply created a new category out of thin air that excludes it.
Dr. Allen Frances from Duke University in North Carolina says this change is nothing more than "a fad in evolution," worrying that even more children will be misdiagnosed with ADHD when they are perfectly normal and healthy. This blatant attempt at medicating as many children as possible has also been described as "disease-mongering," practitioners of which include drug giant Eli Lilly, which is set to release new drugs for SCT that will rake in billions.
"'Sluggish Cognitive Tempo' may possibly be the very dumbest and most dangerous diagnostic idea I have ever encountered," wrote Dr. Allen Frances, M.D., for Psychology Today.
"Child psychology/psychiatry/pediatrics/family medicine have become fevered fields of diagnostic excess, pharmaceutical manipulation, and careless medication prescription," he added. "In just 20 years, rates of ADHD have tripled and Autism and childhood Bipolar Disorder have increased 40-fold."
Like many others, Dr. Frances agrees that the ADHD "epidemic" is nothing but contrived chicanery, pointing out a New York Times series by investigative journalist Alan Schwartz that reveals the extent of the scam.
"Egged on by well meaning (and not so well meaning) experts and by greedy drug companies, we are fast approaching this dystopic wonderland of universal childhood mental illness," concluded Dr. Frances. "I would be in despair were it not for my belief that diagnostic exuberance has overplayed its hand and is ripe for a very big humpty-dumpty type fall."